Clinical Trial Update: Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial protocol investigates tislelizumab combined with chemotherapy and all-trans retinoic acid for locally advanced or metastatic esophageal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING